Please enable Javascript to use all features and improve your user experience.
DGHM 2023
Programme
Posters
People
Search
EN
All people
Juliane Mees
Würzburg, DE
Universitätsklinikum Würzburg
Sort by Type
Date
Chair
19/09/2023
14:00
–
15:30
Workshop
Multidrug-resistant Organisms (MDRO) and other nosocomial Pathogens (FG PR HY/StAG Hyg) 3
Hörsaal 4
IPC and MDRO and nosocomial pathogens (FG PR HY/StAG Hyg)
Speaker
18/09/2023
13:30
–
13:43
10 Min.
3 Min.
Vortrag
PRHYV 023
Influencing factors of lethality in hospitalized patients with acute respiratory infections
IPC and respiiratory infections (FG PR HY/StAG Hyg)
18/09/2023
Poster
PRHYP 215
Estimation of the number of unreported SARS-CoV-2 infections using different indicators
IPC and respiiratory infections (FG PR HY/StAG Hyg)
Further involvements
18/09/2023
13:30
–
13:43
10 Min.
3 Min.
Vortrag
PRHYV 023
Influencing factors of lethality in hospitalized patients with acute respiratory infections
IPC and respiiratory infections (FG PR HY/StAG Hyg)
18/09/2023
13:43
–
13:56
10 Min.
3 Min.
Vortrag
PRHYV 024
Longitudinal evaluation of Influenza A seroconversion and its determinants among healthcare workers in the 2022/23 winter season
IPC and respiiratory infections (FG PR HY/StAG Hyg)
18/09/2023
14:22
–
14:35
10 Min.
3 Min.
Vortrag
PRHYV 027
Quality of life and ability to work after SARS-CoV-2 infections – six-month data from a prospective, controlled cohort study
IPC and MDRO and nosocomial pathogens (FG PR HY/StAG Hyg)
18/09/2023
Poster
PRHYP 215
Estimation of the number of unreported SARS-CoV-2 infections using different indicators
IPC and respiiratory infections (FG PR HY/StAG Hyg)
19/09/2023
Poster
IIP 261
Bivalent BNT162b2mRNA original/Omicron BA.4-5 booster vaccination: adverse reactions and inability to work compared to the monovalent COVID-19 booster
Infektionsimmunologie, Wirt-basierte Therapien, Impfstoffe (FG II)
19/09/2023
Poster
IIP 263
The relationship between mental health, sleep quality, and the immunogenicity of COVID 19 vaccinations
Infektionsimmunologie, Wirt-basierte Therapien, Impfstoffe (FG II)
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy